Seres Therapeutics, Inc.

Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome. We are an exceptional team of drug development and microbiome experts. Our leadership team, board of directors and scientific advisory board have vast experience in the discovery, development, regulatory approval, and successful commercialization of a wide range of therapeutic products. Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics.